Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling

Journal of Psychiatric Research

Volumn 36, Issue 3, 2002, Pages 119-129

  Landgrebe, J ^a   Welzl, G ^b   Metz, T ^b   Van Gaalen, M M ^a   Ropers, H ^c   Wurst, W ^a,b   Holsboer, F ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Antidepressant; Microarray; Mirtazapine; Mouse; Paroxetin; PCA

Indexed keywords

ANTIDEPRESSANT AGENT; COMPLEMENTARY DNA; MIRTAZAPINE; PAROXETINE; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EXPRESSED SEQUENCE TAG; GENE ACTIVITY; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; MALE; MOUSE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RNA EXTRACTION; RNA HYBRIDIZATION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; DNA, COMPLEMENTARY; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION PROFILING; MALE; MIANSERIN; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAROXETINE;

EID: 0036124945     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00061-9     Document Type: Article

References (48)

1. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat
2. Singular value decomposition for genome-wide expression data processing and modeling
3. The SWISS-PROT protein sequence data bank and its supplement TREMBL
4. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level
5. Molecular classification of cutaneous malignant melanoma by gene expression profiling
6. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat
7. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications
8. Ratio-based decisions and the quantitative analysis of cDNA micro-array images
9. Sertraline. A pharmacoeconomic evaluation of its use in depression
10. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness
11. A molecular and cellular theory of depression
12. Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment
13. DNA arrays for analysis of gene expression
14. Cluster analysis and display of genome-wide expression patterns
15. Correspondence analysis applied to microarray data
16. Gene shaving as a method for identifying distinct sets of genes with similar expression patterns
17. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
18. The corticosteroid receptor hypothesis of depression
19. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
20. Fundamental patterns underlying gene expression profiles: Simplicity from complexity
21. Initiation and adaptation: A paradigm for understanding psychotropic drug action
22. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments
23. Regulation of striatal dopamine receptors by corticosterone: An in vivo and in vitro study
24. Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridisations
25. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine
26. Early neocortical regionalization in the absence of thalamic innervation
27. Regulation of c-Fos and NGF1-A by antidepressant treatments
28. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
29. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones
30. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment
31. Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain
32. Differential induction of NF-kappaB activity and neural cell death by antidepressants in vitro
33. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
34. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
35. Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors
36. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant
37. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression
38. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
39. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine
40. Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via alpha 2 receptors
41. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus
42. Transcriptional and translational regulation of phosphodiesterase type IV isozymes in rat brain by electroconvulsive seizure and antidepressant drug treatment
43. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
44. Principal component analysis for grouped data - A case study
45. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment
46. Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone
47. High-fidelity mRNA amplification for gene profiling